Multiple sclerosis (MS) is an immune-related aliment that causes a break down in the central nervous system (CNS). Millions of people are inflected with this disease worldwide. The neurodegeneration that happens when MS attacks the CNS affects various cognitive, sensory, and motor problems and are accompanied by spams and pain.
Though there are current treatments to slow down the process of CNS “lesions and neurological relapses caused by the entry of cells of the peripheral immune system into the CNS”. If treatment is not started immediately following diagnosis, there is no reversal in the nerve loss and the neurodegenerative effects from the inflammation are irreversible. Many of the pharmaceutical treatments available, while helpful in alleviating some symptoms, have significant side effects.
Here is the full scientific article if you wish to download it.
MS is linked to the endocannabinoid system (ECS), which is responsible for synaptic regulation in the CNS as well as the peripheral organs and tissues. He cannabinoid 1 receptors (CB1) are responsible for regulating the hypo/hyperactivation that is in the CNS. Studies are showing that using cannabis to stimulate the CB1 receptors has therapeutic outcomes related to MS. Cannabis is found to not only help with pain management but also spasticity.
“THC is the major therapeutic chemical within cannabis… However, it appears that CBD is not inert and may have some medicinal value”. CBD has immunosuppressive properties that provide not only a reduction in progression but also the severity of the disease.
Cannabis-based cannabinoids produce not only an anti-inflammatory and antioxidant effects, but also produce a neuroprotective enzyme which works to reduce the neurodegenerative effects as well as better cognitive and functional recovery. While it’s lacking a large number of studies, it’s important to be open-minded on the topic of medical cannabis.